annb0t
Top 20
Recce Pharmaceuticals
Highlights:
Independent Safety Committee unanimously recommends cohort four (RECCE® 327 at 1,000mg) to commence; a 20-fold increase from cohort one dose (50mg) Cohort four subjects recruited - RECCE® 327 at 1,000mg dosing started on March 7, 2022 All subjects to be intravenously dosed this week
SYDNEY, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing new classes of synthetic anti-infect...
>>> Read more: Recce Pharmaceuticals Announces Safety Committee Clears Next Dose in Phase I Study of RECCE® 327
Highlights:
Independent Safety Committee unanimously recommends cohort four (RECCE® 327 at 1,000mg) to commence; a 20-fold increase from cohort one dose (50mg) Cohort four subjects recruited - RECCE® 327 at 1,000mg dosing started on March 7, 2022 All subjects to be intravenously dosed this week
SYDNEY, Australia, March 08, 2022 (GLOBE NEWSWIRE) -- Recce Pharmaceuticals Ltd (ASX:RCE, FSE:R9Q) (the Company), the Company developing new classes of synthetic anti-infect...
>>> Read more: Recce Pharmaceuticals Announces Safety Committee Clears Next Dose in Phase I Study of RECCE® 327
